SINGAPORE, July 1, 2026 /PRNewswire/ — NICE Surgical Solutions Pte Ltd (“NICE Surgical”), a clinical-stage medical device company pioneering full intracorporeal anastomosis surgical instruments has been officially granted the U.S. Patent No. 12,653,527 B2, for its purse-string stapler.
SkylineDX’s test stratifies cutaneous melanoma patients into metastatic risk categories to inform treatment decisions.
BLOOMINGTON, Minn., June 30, 2026 /PRNewswire/ — Saluda Medical, Inc. (ASX: SLD, “Saluda” or the “Company”), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Saluda’s CAP24 paddle lead, allowing it to be marketed and sold in the U.S.
Powassan virus spreads through infected ticks, raising concern in Maine and Rhode Island, and symptoms can make the infection dangerous.
New study finds biomarkers that may someday help clinicians better detect—and possibly cure—early and persistent Borrelia burgdorferi infections
Sensitive test looking for key genetic mutation detects high-risk patients missed by standard testing
Aurenar announced today that it received FDA breakthrough device designation for its V-Link noninvasive neuromodulation system.
Novocure (Nasdaq:NVCR) announced today that its Optune Pax device for treating pancreatic cancer received CE mark approval.
StarMed announced today that it received FDA 510(k) clearance for its platform that delivers radiofrequency (RF) ablation of thyroid nodules.
MINNEAPOLIS, June 29, 2026 /PRNewswire/ — Laplace Interventional today announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) for TRIUMPH, the company’s pivotal trial evaluating its Transcatheter Tricuspid Valve Replacement (TTVR) system.